Clinical trial No longer in our active list Interventional Ages 18 to 45 Women only

Infusion of Norepinephrine and Phenylephrine for Preeclampsia During Cesarean Section

Official title: Comparison of Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia During Cesarean Section: a Randomized, Controlled Trial

Run by General Hospital of Ningxia Medical University · NCT05035498 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if giving norepinephrine and phenylephrine during a C-section can help women with preeclampsia maintain stable blood pressure and improve blood flow to the placenta.

More Hemodynamic Instability trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment72 (estimated)
SponsorGeneral Hospital of Ningxia Medical University
Academic / other
Locations1 site (Yinchuan, Ningxia)
Trial IDNCT05035498 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-45 with singleton pregnancies of at least 32 weeks scheduled for cesarean section under spinal anesthesia.

Probably not a fit

Patients with severe hypertension, eclampsia, or significant fetal distress may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of prophylactic norepinephrine and phenylephrine infusion on maternal cardiac output in patients with preeclampsia undergoing cesarean section under spinal anesthesia. Preeclampsia, affecting 5% to 7% of pregnant women, can lead to significant complications, including maternal and neonatal morbidity. The research aims to determine if these infusions can prevent postspinal anesthesia hypotension, which occurs in a notable percentage of preeclamptic patients. By improving hemodynamic stability, the study seeks to enhance placental perfusion during surgery.

Why it matters

Potential benefit: If successful, this approach could significantly improve maternal and neonatal outcomes during cesarean sections for patients with preeclampsia.

How similar studies have gone: While the use of norepinephrine in this context is gaining traction, the specific hemodynamic effects of prophylactic infusion in preeclamptic patients remain largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-45 years
* Primipara or multipara
* Singleton pregnancy ≥32 weeks
* American Society of Anesthesiologists physical status classification II to III
* Scheduled for cesarean section under spinal anesthesia

Exclusion Criteria:

* Baseline blood pressure ≥180 mmHg
* Body height \< 150 cm
* Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
* Eclampsia or chronic hypertension
* Hemoglobin \< 7g/dl
* Fetal distress, or known fetal developmental anomaly

Where it's running

  • General Hospital of Ningxia Medical University
    Yinchuan, Ningxia, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.